Resistance Rates of Mycobacterium Tuberculosis Complex Isolates Obtained From Clinical Samples to Major Antituberculous Drugs: a Study in Edirne, Turkey

dc.contributor.authorÖner, Ozan
dc.contributor.authorÖzdemir, İnan Erdem
dc.contributor.authorElmacı, Kubilay
dc.contributor.authorEryıldız, Canan
dc.date.accessioned2021-11-20T10:26:29Z
dc.date.available2021-11-20T10:26:29Z
dc.date.issued2018
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Fizyoloji Anabilim Dalıen_US
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Mikrobiyoloji Anabilim Dalıen_US
dc.description.abstractAims: The aim of this study is to reveal the rates of the Mycobacterium tuberculosis complex resistance to major antituberculous drugs (streptomycin, isoniazid, rifampicin, ethambutol) by the evaluation of the specimens that are sent to Trakya University Hospital Microbiology Laboratory. Methods:In this study, laboratory data of the cases that were pre-diagnosed with tuberculosis between 11/02/2016 and 31/12/2017 were scanned retrospectively. To compare the annual data descriptive statistics as arithmetic mean, numbers and percentages were used. Results: Out of 4752 samples, 133 (2.79%) were culture positive. 120 isolates were identified as Mycobacterium tuberculosis complex, while other 13 were defined as Mycobacterium other than tuberculosis. Antimycobacterial susceptibility tests showed that 9 (7.5%) isolates were resistant to streptomycin, 10 (8.33%) isolates to isoniazid, 4 (3.33%) isolates to rifampicin, 4 (3.33) isolates to ethambutol. 5 (4.16%) isolates were multidrug resistant. Conclusion: Antituberculous drug resistance is still a threat for an effective treatment of tuberculosis and streptomycin resistance has increased. However, it is also pointed out that presence of Mycobacterium other than tuberculosis in isolates has increaseden_US
dc.identifier.dergipark439208en_US
dc.identifier.endpage31en_US
dc.identifier.issn2148-4724
dc.identifier.issn2548-0030
dc.identifier.issue2en_US
dc.identifier.startpage28en_US
dc.identifier.urihttps://dergipark.org.tr/tr/pub/tmsj/issue/38047/439208
dc.identifier.urihttps://dergipark.org.tr/tr/download/article-file/498291
dc.identifier.urihttps://hdl.handle.net/20.500.14551/6069
dc.identifier.volume5en_US
dc.language.isoenen_US
dc.publisherTrakya Üniversitesien_US
dc.relation.ispartofTurkish Medical Student Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDrug resistanceen_US
dc.subjecttuberculosisen_US
dc.subjectstreptomycinen_US
dc.titleResistance Rates of Mycobacterium Tuberculosis Complex Isolates Obtained From Clinical Samples to Major Antituberculous Drugs: a Study in Edirne, Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
6069.pdf
Boyut:
510.11 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text